This document discusses the application of management strategies and techniques in the field of toxicology and poisoning management to adequately manage complex poisoning events. It describes how managerial disciplines like quality management, risk management, project management, knowledge management, and other techniques can help optimize processes involved in treating poisoned patients. The document emphasizes that treating poisoning requires not just clinical and pharmaceutical expertise but strong organization. It argues that applying management strategies can help control complex poisoning processes and improve clinical and economic outcomes. Examples of various management tools, theories, and models that could be useful in the toxicology field are provided.
This document discusses the importance of management strategies in toxicology and poisoning situations. It emphasizes the need for rapid and effective emergency procedures, communication systems, qualified clinical staff, documentation, and information sharing to properly treat patients. Adequate management is crucial to efficiently control complex poisoning processes and achieve good clinical and economic outcomes. The document recommends applying various managerial techniques from industries like healthcare, disaster planning, and project management to help optimize the treatment of toxicological events.
This document provides an overview of a book titled "THE MANAGEMENT STRATEGY IN TOXICOLOGY AND POISONING". The book discusses how managerial techniques from various disciplines can be applied in the toxicology and poisoning field to adequately manage complex events like rare poisonings or disasters. It argues that applying strategies related to total quality management, risk management, project management, knowledge management, and other approaches can help prevent incidents, reduce errors, and ensure every activity is properly performed from the initial emergency call through discharge. The document provides examples of various management tools, theories, and skills that could provide useful instruments to supplement traditional toxicology and clinical competencies when treating poisoning events.
The document discusses the role of clinical pharmacists in improving patient outcomes and healthcare systems. It argues that clinical pharmacists can make valuable contributions through their expertise in areas like medicinal chemistry, pharmacology, and pharmacokinetics. When integrated into medical teams using management tools and information technologies, clinical pharmacists can help optimize drug therapies and contain costs while improving clinical outcomes. The document advocates expanding the role of clinical pharmacists and leveraging their skills and knowledge to create more effective and efficient healthcare systems.
The 3-week EIMP course aims to teach participants how to effectively use surveillance systems, apply epidemiological tools to outbreak investigation and management, and lead outbreak investigations. The course covers topics like non-communicable disease epidemiology, public health surveillance, health policy, economics, management, and emergencies response. Participants will learn epidemiological methods, statistical analysis, disease prevention and control strategies. The goal is to enhance participants' skills in epidemiological intelligence gathering and effective disease management. The Malaysian government fully sponsors the program and provides airfare, accommodation, meals and allowances for medical professionals working in public health.
This document summarizes research on rethinking hospital pharmacist services through centralized logistics and clinical pharmaceutical care strategies. It finds that centralized logistics systems can reduce drug and medical device costs through bulk purchasing and inventory management. It also finds that incorporating clinical pharmacists into medical teams can improve clinical outcomes and reduce costs through optimizing medication management, avoiding errors, and monitoring drug therapies. The document reviews literature showing pharmacists improving outcomes and reducing costs by 35% when integrated into oncology medical teams. It proposes a new model with pharmacists playing a more active clinical role to help contain healthcare spending while improving patient care.
This document summarizes the role of clinical pharmacists in diagnostic imaging procedures that utilize contrast agents or radiopharmaceuticals. It discusses how clinical pharmacists are experts in drug management and can help ensure proper use and monitoring of contrast agents and radiopharmaceuticals. The document also reviews literature showing that involvement of clinical pharmacists in imaging procedures can improve patient outcomes and safety while reducing costs.
The document discusses how clinical pharmacists can help reduce healthcare costs when integrated into medical teams. It presents evidence from studies showing that pharmacists improve clinical outcomes and lower costs through various methods. When pharmacists apply diagnostic data and utilize management skills while collaborating with medical staff, they can optimize drug therapy selection and monitoring, reducing costs up to 30% while improving patient care. The inclusion of pharmacists in multidisciplinary teams provides an effective approach for health systems to both enhance quality of care and contain expenses.
This document discusses using new tools like risk analysis, vision zero approach, safety accident reports, and what-if analysis in emergency medicine and pharmacy. These tools can help prevent failures and reduce risks to obtain better clinical outcomes. Specifically, what-if analysis considers potential issues prospectively rather than just looking at historical data. The author argues that incorporating these managerial techniques from other fields into daily emergency work can help minimize failure risks. A multidisciplinary approach including clinical pharmacists on medical teams can also improve decision-making and reduce mortality rates for critically ill patients.
This document discusses the importance of management strategies in toxicology and poisoning situations. It emphasizes the need for rapid and effective emergency procedures, communication systems, qualified clinical staff, documentation, and information sharing to properly treat patients. Adequate management is crucial to efficiently control complex poisoning processes and achieve good clinical and economic outcomes. The document recommends applying various managerial techniques from industries like healthcare, disaster planning, and project management to help optimize the treatment of toxicological events.
This document provides an overview of a book titled "THE MANAGEMENT STRATEGY IN TOXICOLOGY AND POISONING". The book discusses how managerial techniques from various disciplines can be applied in the toxicology and poisoning field to adequately manage complex events like rare poisonings or disasters. It argues that applying strategies related to total quality management, risk management, project management, knowledge management, and other approaches can help prevent incidents, reduce errors, and ensure every activity is properly performed from the initial emergency call through discharge. The document provides examples of various management tools, theories, and skills that could provide useful instruments to supplement traditional toxicology and clinical competencies when treating poisoning events.
The document discusses the role of clinical pharmacists in improving patient outcomes and healthcare systems. It argues that clinical pharmacists can make valuable contributions through their expertise in areas like medicinal chemistry, pharmacology, and pharmacokinetics. When integrated into medical teams using management tools and information technologies, clinical pharmacists can help optimize drug therapies and contain costs while improving clinical outcomes. The document advocates expanding the role of clinical pharmacists and leveraging their skills and knowledge to create more effective and efficient healthcare systems.
The 3-week EIMP course aims to teach participants how to effectively use surveillance systems, apply epidemiological tools to outbreak investigation and management, and lead outbreak investigations. The course covers topics like non-communicable disease epidemiology, public health surveillance, health policy, economics, management, and emergencies response. Participants will learn epidemiological methods, statistical analysis, disease prevention and control strategies. The goal is to enhance participants' skills in epidemiological intelligence gathering and effective disease management. The Malaysian government fully sponsors the program and provides airfare, accommodation, meals and allowances for medical professionals working in public health.
This document summarizes research on rethinking hospital pharmacist services through centralized logistics and clinical pharmaceutical care strategies. It finds that centralized logistics systems can reduce drug and medical device costs through bulk purchasing and inventory management. It also finds that incorporating clinical pharmacists into medical teams can improve clinical outcomes and reduce costs through optimizing medication management, avoiding errors, and monitoring drug therapies. The document reviews literature showing pharmacists improving outcomes and reducing costs by 35% when integrated into oncology medical teams. It proposes a new model with pharmacists playing a more active clinical role to help contain healthcare spending while improving patient care.
This document summarizes the role of clinical pharmacists in diagnostic imaging procedures that utilize contrast agents or radiopharmaceuticals. It discusses how clinical pharmacists are experts in drug management and can help ensure proper use and monitoring of contrast agents and radiopharmaceuticals. The document also reviews literature showing that involvement of clinical pharmacists in imaging procedures can improve patient outcomes and safety while reducing costs.
The document discusses how clinical pharmacists can help reduce healthcare costs when integrated into medical teams. It presents evidence from studies showing that pharmacists improve clinical outcomes and lower costs through various methods. When pharmacists apply diagnostic data and utilize management skills while collaborating with medical staff, they can optimize drug therapy selection and monitoring, reducing costs up to 30% while improving patient care. The inclusion of pharmacists in multidisciplinary teams provides an effective approach for health systems to both enhance quality of care and contain expenses.
This document discusses using new tools like risk analysis, vision zero approach, safety accident reports, and what-if analysis in emergency medicine and pharmacy. These tools can help prevent failures and reduce risks to obtain better clinical outcomes. Specifically, what-if analysis considers potential issues prospectively rather than just looking at historical data. The author argues that incorporating these managerial techniques from other fields into daily emergency work can help minimize failure risks. A multidisciplinary approach including clinical pharmacists on medical teams can also improve decision-making and reduce mortality rates for critically ill patients.
The document discusses the role of pharmacists in antimicrobial stewardship and infection prevention and control. It states that pharmacists have a responsibility to take prominent roles in antimicrobial stewardship programs and participate in infection prevention efforts through activities focused on appropriate antimicrobial use and membership on multidisciplinary committees. Some of the key responsibilities of pharmacists include promoting optimal antimicrobial use, reducing infection transmission, and educating others about antimicrobial stewardship and infection prevention.
Health Technology Assessments in Indiashashi sinha
The document provides an overview of health technology assessment (HTA) in India. It discusses how HTA can help optimize resource allocation and ensure affordable access to essential healthcare as part of India's universal health coverage agenda. The HTAIn was established to conduct HTA studies to inform decision making. HTAIn's objectives include maximizing health outcomes while reducing costs and inequality. It has completed several studies that have informed policies on topics like safety engineered syringes, intraocular lenses for cataracts, and long acting contraceptives. Ongoing studies cover additional health technologies. HTAIn aims to support evidence-based policies to expand coverage and financial risk protection.
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.
The REQueST tool was developed to evaluate patient registries for their suitability for health technology assessment. It contains sections on methodological information, essential standards, and additional requirements. While many aspects of registries are considered, the tool focuses on those most relevant to outcomes assessment. Key items include ensuring objectives define proper data collection and address HTA questions, outcomes are clearly defined and aligned with data standards, and analysis considers confounding factors and data cleaning. The tool allows assessment agencies to consistently evaluate registries and supports registry holders in designing robust outcomes data collection.
The document discusses various methods for measuring outcomes in pharmacoepidemiology studies. It describes outcome measures like functional status, symptom status, patient satisfaction, and quality of life. It also discusses approaches to measuring outcomes, including outcome measures and drug use measures. It provides definitions and explanations of key epidemiological terms used to measure outcomes, such as prevalence, incidence rates, morbidity, mortality, case fatality rates, and survival rates. It also defines various ways to measure drug use, including monetary units, prescriptions, drug units dispensed, defined daily doses, and adherence measurements.
New technologies have the potential to improve clinical outcomes in toxicology and poisoning situations. The literature review identified several technologies that could help, such as expert systems to manage emergency drug stocks and antidote programs. Studies found that most hospitals have inadequate stocks of important antidotes. Guidelines and collaboration between hospitals, including formal stock sharing agreements, could help address shortages. The implementation of a computerized pharmacy cabinet system in one hospital reduced costs by 75,000 euros over 5 years while still covering 99% of emergency needs. New technologies, if properly managed by clinical staff, may lead to more effective antidote availability and improved patient outcomes in toxicology emergencies.
Patient Safety: Evolving from Compliance to Cultureclinicalsolutions
Patient Safety, evolving from Compliance to Culture with McKesson http://www.mckesson.com/static_files/McKesson.com/MPT/Documents/PatientSafety_WHT260.pdf
This document provides an overview of pharmacoeconomics. It defines pharmacoeconomics as the application of economic analysis to pharmaceutical products and services, focusing on costs and outcomes. The document then covers:
- The history and perspectives of pharmacoeconomics
- Common methodologies like cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis
- How pharmacoeconomics can be applied at different stages of drug development and to support pricing and reimbursement decisions
- The relationships between pharmacoeconomics, outcomes research, and pharmaceutical care
In 3 sentences or less, this document summarizes key concepts in pharmacoeconomics like its definition, common methodologies, and applications in drug
This document summarizes a research article about using professional social media to connect healthcare researchers. It finds that social media provides a rapid way to connect researchers worldwide and share information like profiles, publications and expertise. However, more optimization is needed to tailor connections to specific needs and applications. While sites like PubMed and LinkedIn are useful, the researchers propose developing a new scientific social network that combines features of existing sites to better meet the needs of researchers and society.
This document discusses pharmacoeconomics and its importance in balancing the interests of stakeholders in the healthcare industry. It begins by defining health economics and pharmacoeconomics, and explaining their relationship. It then discusses the shift in focus of healthcare consumers towards disease prevention. The document outlines various challenges faced by the healthcare industry and how pharmacoeconomic solutions can address the perspectives of patients, physicians, insurers, manufacturers, researchers and policymakers. It provides a case study on drug selection for osteoarthritis using pharmacoeconomic analysis. Finally, it discusses the global presence and potential for establishing pharmacoeconomics in India.
This document provides a comparative survey of health technology assessment (HTA) in Brazil, China, and India. It finds that Brazil has established the most advanced centralized HTA framework, including a national HTA commission called CONITEC that advises the Ministry of Health. China has begun emphasizing HTA but lacks a unified system, while HTA in India is limited. The study identifies lessons from Brazil's experience that may transfer to emerging countries, like China, seeking to implement HTA.
International conference-harmonisation-technical-requirements-registration-ph...ibrahimbouzina
This document provides guidance on quality risk management principles and tools for use across the pharmaceutical product lifecycle. It outlines a general quality risk management process that includes risk assessment, control, communication and review. The level of effort for quality risk management should be commensurate with the level of risk. Quality risk management can help facilitate more informed decision making and regulatory oversight while ensuring product quality protects patient safety.
The document summarizes the concept, criteria for selection, benefits, and application of essential medicines in Nepal. Essential medicines are those that satisfy the priority health needs of the population and are intended to be available at all times in adequate amounts and appropriate forms at a price people can afford. Nepal first implemented a national list of essential medicines in 1986 based on WHO guidelines. The list is revised every few years to ensure availability of effective, safe, and affordable medicines aligned with treatment guidelines.
This document discusses how clinical pharmaceutical care, medical laboratory imaging, and nuclear medicine can work together to improve clinical outcomes and reduce costs. It argues that clinical pharmacists are well-positioned to utilize data from these areas to better monitor drug therapies and collaborate as part of multidisciplinary medical teams. Several studies are cited that show involvement of clinical pharmacists on medical teams can significantly improve various clinical outcomes and lower mortality rates. The inclusion of pharmacists' expertise in areas like medical imaging and laboratory testing is posited to further aid rational drug therapy management and containment of treatment costs.
Stratified medicine uses biomarkers to classify patients into subgroups for clinical trials and treatment. This requires closer integration of diagnostic and therapeutic development. Only a few companies have both diagnostic and therapeutic capabilities, so partnerships are common. There is uncertainty around who funds biomarker discovery and validation, with options including spin-offs, government programs, in-house pharma efforts, and pharma partnerships. Stratified medicine increases demand for biomarkers and companion diagnostics but also complexity across development processes.
Ethical and Participant Safety considerations in Clinical TrialsKunal Sampat
This document discusses key ethical considerations for clinical trial protocols and conduct. It outlines standard protocol elements such as format, content, and administrative responsibilities. Some important ethical considerations in protocol development include appropriate inclusion/exclusion criteria, choice of efficacy and safety parameters, and procedures for handling medical emergencies and early trial discontinuation. When conducting trials, important ethical areas are recruiting and screening patients, maintaining confidentiality of data, and following the Declaration of Helsinki for protecting human subjects.
Development of Translational Medicine at Univ. of Medicine & Pharmacy (UMP), ...Thai Nguyen PeterTigr
UMP is now taking the new challenge in developing modern biomedical research to align our scientific programs with the international medical community, and importantly, to harness the advancements of biological sciences for medical services, via translational research, for unmet medical illnesses of the Vietnamese patients.
This document discusses the importance of implementing management tools and techniques in toxicology and poisoning organizations to improve outcomes. It argues that applying concepts from business management can help optimize various parts of the toxicology treatment process. These may include project management, risk management, quality management, and information and communication technologies. The document presents evidence that management approaches have led to positive results in other settings and could similarly enhance the efficacy of poisoning treatment systems if adopted in healthcare toxicology organizations.
The document discusses the increasing role of clinical pharmacists in managing medical devices in healthcare. It notes that medical devices contribute greatly to many surgical and therapeutic procedures. Clinical pharmacists are well-suited to help contain costs related to medical devices through activities like ensuring appropriate device selection and use, consulting on properties and regulations of different classes of devices, and training medical teams. The role of pharmacists in medical device management is expected to grow further given new diagnostic technologies and the reclassification of some products from drugs to devices.
The document discusses the role of pharmacists in antimicrobial stewardship and infection prevention and control. It states that pharmacists have a responsibility to take prominent roles in antimicrobial stewardship programs and participate in infection prevention efforts through activities focused on appropriate antimicrobial use and membership on multidisciplinary committees. Some of the key responsibilities of pharmacists include promoting optimal antimicrobial use, reducing infection transmission, and educating others about antimicrobial stewardship and infection prevention.
Health Technology Assessments in Indiashashi sinha
The document provides an overview of health technology assessment (HTA) in India. It discusses how HTA can help optimize resource allocation and ensure affordable access to essential healthcare as part of India's universal health coverage agenda. The HTAIn was established to conduct HTA studies to inform decision making. HTAIn's objectives include maximizing health outcomes while reducing costs and inequality. It has completed several studies that have informed policies on topics like safety engineered syringes, intraocular lenses for cataracts, and long acting contraceptives. Ongoing studies cover additional health technologies. HTAIn aims to support evidence-based policies to expand coverage and financial risk protection.
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.
The REQueST tool was developed to evaluate patient registries for their suitability for health technology assessment. It contains sections on methodological information, essential standards, and additional requirements. While many aspects of registries are considered, the tool focuses on those most relevant to outcomes assessment. Key items include ensuring objectives define proper data collection and address HTA questions, outcomes are clearly defined and aligned with data standards, and analysis considers confounding factors and data cleaning. The tool allows assessment agencies to consistently evaluate registries and supports registry holders in designing robust outcomes data collection.
The document discusses various methods for measuring outcomes in pharmacoepidemiology studies. It describes outcome measures like functional status, symptom status, patient satisfaction, and quality of life. It also discusses approaches to measuring outcomes, including outcome measures and drug use measures. It provides definitions and explanations of key epidemiological terms used to measure outcomes, such as prevalence, incidence rates, morbidity, mortality, case fatality rates, and survival rates. It also defines various ways to measure drug use, including monetary units, prescriptions, drug units dispensed, defined daily doses, and adherence measurements.
New technologies have the potential to improve clinical outcomes in toxicology and poisoning situations. The literature review identified several technologies that could help, such as expert systems to manage emergency drug stocks and antidote programs. Studies found that most hospitals have inadequate stocks of important antidotes. Guidelines and collaboration between hospitals, including formal stock sharing agreements, could help address shortages. The implementation of a computerized pharmacy cabinet system in one hospital reduced costs by 75,000 euros over 5 years while still covering 99% of emergency needs. New technologies, if properly managed by clinical staff, may lead to more effective antidote availability and improved patient outcomes in toxicology emergencies.
Patient Safety: Evolving from Compliance to Cultureclinicalsolutions
Patient Safety, evolving from Compliance to Culture with McKesson http://www.mckesson.com/static_files/McKesson.com/MPT/Documents/PatientSafety_WHT260.pdf
This document provides an overview of pharmacoeconomics. It defines pharmacoeconomics as the application of economic analysis to pharmaceutical products and services, focusing on costs and outcomes. The document then covers:
- The history and perspectives of pharmacoeconomics
- Common methodologies like cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis
- How pharmacoeconomics can be applied at different stages of drug development and to support pricing and reimbursement decisions
- The relationships between pharmacoeconomics, outcomes research, and pharmaceutical care
In 3 sentences or less, this document summarizes key concepts in pharmacoeconomics like its definition, common methodologies, and applications in drug
This document summarizes a research article about using professional social media to connect healthcare researchers. It finds that social media provides a rapid way to connect researchers worldwide and share information like profiles, publications and expertise. However, more optimization is needed to tailor connections to specific needs and applications. While sites like PubMed and LinkedIn are useful, the researchers propose developing a new scientific social network that combines features of existing sites to better meet the needs of researchers and society.
This document discusses pharmacoeconomics and its importance in balancing the interests of stakeholders in the healthcare industry. It begins by defining health economics and pharmacoeconomics, and explaining their relationship. It then discusses the shift in focus of healthcare consumers towards disease prevention. The document outlines various challenges faced by the healthcare industry and how pharmacoeconomic solutions can address the perspectives of patients, physicians, insurers, manufacturers, researchers and policymakers. It provides a case study on drug selection for osteoarthritis using pharmacoeconomic analysis. Finally, it discusses the global presence and potential for establishing pharmacoeconomics in India.
This document provides a comparative survey of health technology assessment (HTA) in Brazil, China, and India. It finds that Brazil has established the most advanced centralized HTA framework, including a national HTA commission called CONITEC that advises the Ministry of Health. China has begun emphasizing HTA but lacks a unified system, while HTA in India is limited. The study identifies lessons from Brazil's experience that may transfer to emerging countries, like China, seeking to implement HTA.
International conference-harmonisation-technical-requirements-registration-ph...ibrahimbouzina
This document provides guidance on quality risk management principles and tools for use across the pharmaceutical product lifecycle. It outlines a general quality risk management process that includes risk assessment, control, communication and review. The level of effort for quality risk management should be commensurate with the level of risk. Quality risk management can help facilitate more informed decision making and regulatory oversight while ensuring product quality protects patient safety.
The document summarizes the concept, criteria for selection, benefits, and application of essential medicines in Nepal. Essential medicines are those that satisfy the priority health needs of the population and are intended to be available at all times in adequate amounts and appropriate forms at a price people can afford. Nepal first implemented a national list of essential medicines in 1986 based on WHO guidelines. The list is revised every few years to ensure availability of effective, safe, and affordable medicines aligned with treatment guidelines.
This document discusses how clinical pharmaceutical care, medical laboratory imaging, and nuclear medicine can work together to improve clinical outcomes and reduce costs. It argues that clinical pharmacists are well-positioned to utilize data from these areas to better monitor drug therapies and collaborate as part of multidisciplinary medical teams. Several studies are cited that show involvement of clinical pharmacists on medical teams can significantly improve various clinical outcomes and lower mortality rates. The inclusion of pharmacists' expertise in areas like medical imaging and laboratory testing is posited to further aid rational drug therapy management and containment of treatment costs.
Stratified medicine uses biomarkers to classify patients into subgroups for clinical trials and treatment. This requires closer integration of diagnostic and therapeutic development. Only a few companies have both diagnostic and therapeutic capabilities, so partnerships are common. There is uncertainty around who funds biomarker discovery and validation, with options including spin-offs, government programs, in-house pharma efforts, and pharma partnerships. Stratified medicine increases demand for biomarkers and companion diagnostics but also complexity across development processes.
Ethical and Participant Safety considerations in Clinical TrialsKunal Sampat
This document discusses key ethical considerations for clinical trial protocols and conduct. It outlines standard protocol elements such as format, content, and administrative responsibilities. Some important ethical considerations in protocol development include appropriate inclusion/exclusion criteria, choice of efficacy and safety parameters, and procedures for handling medical emergencies and early trial discontinuation. When conducting trials, important ethical areas are recruiting and screening patients, maintaining confidentiality of data, and following the Declaration of Helsinki for protecting human subjects.
Development of Translational Medicine at Univ. of Medicine & Pharmacy (UMP), ...Thai Nguyen PeterTigr
UMP is now taking the new challenge in developing modern biomedical research to align our scientific programs with the international medical community, and importantly, to harness the advancements of biological sciences for medical services, via translational research, for unmet medical illnesses of the Vietnamese patients.
This document discusses the importance of implementing management tools and techniques in toxicology and poisoning organizations to improve outcomes. It argues that applying concepts from business management can help optimize various parts of the toxicology treatment process. These may include project management, risk management, quality management, and information and communication technologies. The document presents evidence that management approaches have led to positive results in other settings and could similarly enhance the efficacy of poisoning treatment systems if adopted in healthcare toxicology organizations.
The document discusses the increasing role of clinical pharmacists in managing medical devices in healthcare. It notes that medical devices contribute greatly to many surgical and therapeutic procedures. Clinical pharmacists are well-suited to help contain costs related to medical devices through activities like ensuring appropriate device selection and use, consulting on properties and regulations of different classes of devices, and training medical teams. The role of pharmacists in medical device management is expected to grow further given new diagnostic technologies and the reclassification of some products from drugs to devices.
This document discusses the role of clinical pharmacists in surgery teams. It argues that clinical pharmacists are drug experts who can improve surgical outcomes through their expertise in areas like pharmacokinetics, antimicrobial stewardship, and management of anesthesia drugs. The inclusion of clinical pharmacists in multidisciplinary teams has been shown to reduce mortality rates in intensive care units. The document calls for clinical pharmacists to have a stable presence in surgical teams in order to rationalize healthcare costs and maximize the benefits to patients.
This document discusses how sharing economy tools like social media and ICT can improve healthcare outcomes and reduce costs. It argues that connecting healthcare professionals through these tools allows for improved knowledge sharing, more rapid dissemination of best practices, and reduced errors and treatment times. The document reports that studies have found 30-40% reductions in healthcare costs when clinical pharmacists are integrated into care teams using sharing economy instruments like social media. It calls for incorporating sharing economy principles and management training into clinical pharmacist education to further optimize healthcare quality and costs.
This document discusses the synergistic relationship between pharmaceutical care and toxicology in high-risk poisoning situations. It argues that having a clinical pharmacist as a permanent member of the toxicology medical team can improve outcomes. The roles of a clinical pharmacist, such as their expertise in pharmacokinetics, toxicology, and antidote management, are highly relevant to treating poisoning cases. Their competencies complement those of physicians. Involving clinical pharmacists in toxicology teams can help optimize treatment, management of antidote supplies, and costs associated with poisoning cases.
This research article discusses management tools that can help clinical pharmacists manage healthcare costs more efficiently. It analyzes current clinical pharmacy university programs and finds that management theory is not typically included as an autonomous discipline. The article then reviews literature on management skills needed in healthcare settings, including planning, organizing, coordinating, controlling staff and budgets. It proposes integrating management training into clinical pharmacy programs to help pharmacists rationalize costs of new therapies and monitor costs of diagnostic procedures and drug therapies. Management tools like strategic planning, benchmarking, and performance analysis can help clinical pharmacists work as active members of medical teams to improve patient outcomes and contain costs.
The document discusses strategies for improving hospital pharmacy services through centralized logistics and increased clinical pharmaceutical care. Centralized logistics systems can reduce drug and medical device costs by increasing bulk purchasing power. This allows hospitals to reduce on-site stock and rely on just-in-time delivery from central warehouses. Implementing information and communication technologies helps coordinate these systems. The role of clinical pharmacists is also emphasized - through multidisciplinary teams, they can help reduce medical errors and costs while improving outcomes. Studies show the presence of clinical pharmacists on medical teams can lower costs by 35% through optimizing treatments and preventing errors.
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?Jackie Brusch
The Internet of Everything (IoE) is having a major impact across many industries by connecting people, processes and data on a single network. The IoE brings opportunities to make clinical trials more efficient, cost-effective and less intrusive by enabling devices, sensors and applications to connect to healthcare systems via the internet. This allows for remote patient monitoring and the collection of real-time objective data from devices and wearables. The constant flow of rich data allows investigators to remotely manage patients' health, which has potential to speed up drug development times. However, clinical trials have yet to fully embrace the IoE and changes may be needed to regulations and processes to realize the IoE's benefits for research.
18
Annotated Bibliography
3164 words
Rough Draft on Infection Control
by
Submitted to
Semester
Date
Contact
Address
Phone
Email
Infection Control
2
Introduction of the Paper
Background
According to various reports by the Centers for Disease Control and Prevention, a significant number of lives are lost each passing year due to the spread of infections in hospitals that could otherwise have been prevented. 3 Therefore, effort geared towards understanding infection control plays a significant role in reducing the otherwise unnecessary loss of lives. Infection control entails the power to directly prevent or determine the spread of infections with the aim of avoiding it. 4 Indeed, the pathological state resulting from the invasion of the body by pathogenic microorganisms has far-reaching consequences. While so much has been done to prevent its spread, there is still a lot more to be done. This research paper intends to focus on Healthcare-associated Infections and how it can be prevented if not eliminated altogether.
Statement of the Problem
Healthcare-Associated Infections are a common occurrence in the modern healthcare setting resulting in huge financial losses and loss of lives. According to the Office of Disease Prevention and Healthcare Promotion (ODPHP), these are infections that patients contract while receiving treatment in a medical facility. Percival, Suleman, Vuotto & Donelli, (2015) pointed out that its prevalence is as a result of the employment of invasive devices and procedures meant to treat patients and to help them recover. 6 While most of them are accidental in nature, they still remain to be seen as accidents that could have been prevented. The US government, through the establishment of Healthy People 2020 and the U.S. Department of Health and Human Services (HHS) have taken a lead role in spreading the news on infection control. To that effect, recent research reveals that there could be a 70% reduction in infections by implementing existing prevention practices. This translates to a financial benefit estimated to be $31.5 billion in medical cost savings (ODPHP, 2019). Understanding these prevention measures should, therefore, be a priority to all healthcare practitioners. That is why this research study intends to shade more light on nosocomial infections. These are infections that occur within 48 hours upon admission into a hospital. They can also occur in three days of discharge or 30 days of operation. They affect one in every 10 patients admitted in a hospital. 5, 7
The rationale for addressing the issue
Addressing this issue is important to the health sector from a political, social as well as environmental perspective. As a matter of fact, its impact will be on a short term, interim basis and long term basis. Politically, health has always been a major subject of concern as it is used by voters to determine how best an administration has taken care of their needs. Establishing an infection contro.
This document discusses velocity management strategy and its potential applications in healthcare. Velocity management uses time management tools and techniques from fields like the military to rapidly achieve goals and improve business results by 30-40%. It argues that velocity management skills should be added to management education curriculums. Applying these strategies in healthcare through tools like social media, data sharing, and new technologies could reduce global healthcare costs by 30% in areas like ICUs and toxicology. Velocity management's focus on quick decision-making and constant communication could help healthcare managers adapt to today's fast-paced, global competitive environment.
PAGE 1State Pharmacy BrazilnamePracticum in Health Administ.docxalfred4lewis58146
PAGE
1State Pharmacy Brazil
namePracticum in Health Administration
MHA 690Pfeiffer University
November 7, 2013
Professor:
Table of Contents
Introduction ………………………………………………………………
Brazilian Health Care System………………………………………………………….14
The State Pharmacy Exceptional Drugs ……………………………………….…20
Activities…………………………………………………………………………………24
I. Participation in Activities Developed in Sector Screening and Social Services ………………………………………………………………...33
II. Participation in the Passwords Distribution ………………………………………………………………34
III. Participation in the Activities of Pre-Dispensation:……………………………………………………………....35
IV. Participation in the Activities Performed in Pharmaceutical Care ……………………………………………………………36
V. Participation in the Activities of the Internal Pharmacy after the Service
Conclusion………………………………………………………………………38
Bibliography………………………………………………………………….………….……..39
1. INTRODUCTION
The internship was in the State Pharmacy of Curitiba – Brazil. The internship aims to enter the student in daily SUS to analyze the role of the pharmacist in this system with the opportunity to combine theory with practice, to develop time responsibility and competence expected of the pharmacist, and improve theoretical, technical, ethical, and political understanding for the student.
Brazilian Health Care System
The public health system (SUS) is one of the largest public health systems in the world. It ensures universal, comprehensive health care and it is free to the entire population of the country. The public health system was created in 1988 by the Brazilian federal constitution to be the health care for all Brazilians. Besides offering consultations, tests, and hospitalizations, the system also promotes vaccination campaigns, prevention, and sanitary surveillance.
The SUS was created to provide equal service and care, and promote the health of the entire population. The system is a unique social project that materializes through health promotion, prevention, and Brazilians' health care.
For nearly 22 years of existence, the National Health System (SUS) has established itself as a major public policy in Brazil promoting social inclusion and seeking to continuously strengthen their basic pillars of full health care, and universal and equal access. It is the only access to health services for 160 million Brazilians (80% of the population), SUS is developing mechanisms to improve management and expand its scope. In 2009, it performed 3 billion outpatient visits, 380 million medical visits, 280,000 heart surgeries, and 10 million procedures in radiotherapy and chemotherapy. In addition, SUS is one of the largest public organ transplant programs in the world, won international recognition for the success of mass vaccination campaigns, and is the only developing country to guarantee free comprehensive treatment for people with HIV (Brasil, pp 11-13).
The Unified Health System (SUS) was creat.
2
Annotated Bibliography
3164 words
Rough Draft on Infection Control
by
Submitted to
Semester
Date
Contact
Address
Phone
Email
Infection Control
1
Introduction of the Paper
Background
According to various reports by the Centers for Disease Control and Prevention, a significant number of lives are lost each passing year due to the spread of infections in hospitals that could otherwise have been prevented (Alp & Damani, 2015). Therefore, effort geared towards understanding infection control plays a significant role in reducing the otherwise unnecessary loss of lives. Infection control entails the power to directly prevent or determine the spread of infections with the aim of avoiding it (Berríos-Torres, et al., 2017). Indeed, the pathological state resulting from the invasion of the body by pathogenic microorganisms has far-reaching consequences. While so much has been done to prevent its spread, there is still a lot more to be done. This research paper intends to focus on Healthcare-associated Infections and how it can be prevented if not eliminated altogether.
Statement of the Problem
Healthcare-Associated Infections are a common occurrence in the modern healthcare setting resulting in huge financial losses and loss of lives. According to the Office of Disease Prevention and Healthcare Promotion (ODPHP), these are infections that patients contract while receiving treatment in a medical facility. Percival, Suleman, Vuotto & Donelli, (2015) pointed out that its prevalence is as a result of the employment of invasive devices and procedures meant to treat patients and to help them recover. While most of them are accidental in nature, they still remain to be seen as accidents that could have been prevented. The US government, through the establishment of Healthy People 2020 and the U.S. Department of Health and Human Services (HHS) have taken a lead role in spreading the news on infection control. To that effect, recent research reveals that there could be a 70% reduction in infections by implementing existing prevention practices. This translates to a financial benefit estimated to be $31.5 billion in medical cost savings (ODPHP, 2019). Understanding these prevention measures should, therefore, be a priority to all healthcare practitioners. That is why this research study intends to shade more light on nosocomial infections. These are infections that occur within 48 hours upon admission into a hospital. They can also occur in three days of discharge or 30 days of operation. They affect one in every 10 patients admitted in a hospital (Khan, Baig & Mehboob, 2017; Suleyman, & Alangaden, 2016).
Rationale for addressing the issue
Addressing this issue is important to the health sector from a political, social as well as environmental perspective. As a matter of fact, its impact will be on a short term, interim basis and long term basis. Politically, health has always been a major subject of concern as it is used by voters to determi.
This document provides an overview of a presentation on health research. It defines research and outlines its aims and classifications. It discusses identifying research problems and the knowledge management cycle. It emphasizes that research should address real community problems and be action-oriented to inform policymakers and ultimately improve public health.
Agile Drug Development Required in a New Age of UrgencyCognizant
This document discusses the need for more agile drug development processes to deal with global pandemics like COVID-19. It argues that current drug development and regulatory paradigms are too slow and were not designed to address rapidly spreading diseases. The document advocates complementing traditional randomized clinical trials with accelerated real-world evidence studies and real-time clinical analysis using technologies like electronic health records. It also suggests leveraging digital technologies to more quickly develop and deploy experimental therapies that show promise during health emergencies while continuing to monitor safety and efficacy. Three life sciences experts provide perspectives and believe regulatory frameworks need to be rethought to allow faster response times on the order of weeks instead of months or years during pandemics.
CONNECTED HEALTH Thesis - Loïc RICCI ReportLoïc RICCI
This document is an abstract for a thesis paper on the potential benefits of connected health for users and society. The paper explores the growing field of connected health and its applications. The author argues that connected health, which collects health information through sensors and monitors patients remotely, has the potential to maximize human life expectancy and quality by providing constant health monitoring and early detection of health issues. However, widespread adoption of connected health also faces challenges regarding data security, technological barriers for users, impacts on the healthcare industry workforce, and determining appropriate regulations and oversight. The thesis will examine both the benefits of connected health as well as the issues that need to be addressed for its effective implementation.
Intensive Healthcare Facilities and Rooms.pdfbkbk37
1) Pandemic preparedness in healthcare facilities is important to minimize the impact and spread of pandemics.
2) Current healthcare facilities are often underprepared with inadequate equipment, supplies, and training to effectively respond to pandemics.
3) Developing comprehensive pandemic preparedness policies and strategies can help healthcare workers obtain necessary resources to fight pandemics and save lives.
The document discusses the potential benefits of including clinical pharmacists as active members of medical teams in drug registration clinical trials. It notes that clinical pharmacist involvement in regular medical care has been shown to improve certain clinical outcomes. However, clinical pharmacists are not currently required to have an active role in registration trials, which aim to obtain the best clinical results to ensure drug safety and efficacy. The inclusion of clinical pharmacists in registration trials could help rationalize decision making and potentially improve trial results by reducing issues like undetected toxicity or suboptimal drug selection that cause patients to leave trials early. For these reasons, the document argues that regulatory agencies should require clinical pharmacist participation in new clinical trials.
This document discusses how clinical pharmaceutical care and new healthcare technologies can synergize to significantly reduce healthcare costs. It argues that information and communication technology systems can reduce medical errors and waste when combined with the clinical expertise of hospital pharmacists. Specifically, technologies like dose drug unit systems, electronic medical records, and automated dispensing cabinets paired with pharmacists' monitoring of drug therapies can rationalize costs by an estimated 40% by optimizing treatment and minimizing errors. The author advocates for recognizing clinical pharmaceutical care as a new healthcare discipline that harnesses management principles and technologies.
The document discusses the importance of consumer reporting of adverse drug reactions (ADRs) in Malaysia. It notes that while Malaysia has a national pharmacovigilance program, it suffers from weaknesses like under-reporting and a lack of consumer involvement. Consumer reporting can help address under-reporting by capturing ADRs not reported by healthcare professionals. It also promotes consumer rights and participation. The document argues for establishing a consumer reporting program in Malaysia and enhancing the existing national pharmacovigilance program through improved awareness, a national drug prescription database, and strategies to improve reporting.
COMMUNITY PHARMACY PRESENTATION FINAL.pptxsardarjarrar
This document discusses the application of statistics in medical research and pharmacy. It begins by defining statistics and medical research. It then explains the relationship between medical sciences and statistical approaches, and lists some commonly used statistical tools in medical research like descriptive statistics, inferential statistics, chi square, correlation and regression. The document gives examples of how statistics are applied in areas like data collection, resource allocation, quality improvement, pharmacology, public health, and pharmaceutical marketing. It emphasizes the importance of statistical data in drawing reasonable inferences and making accurate decisions in medical research.
Similar to Research article the management strategy in toxicology and poisoning luisetto mauro et al 2019 ijrbsm (20)
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Research article the management strategy in toxicology and poisoning luisetto mauro et al 2019 ijrbsm
1. International Journal of Research in Business Studies and Management
Volume 6, Issue 6, 2019, PP 34-49
ISSN 2394-5923 (Print) & ISSN 2394-5931 (Online)
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 34
The Management Strategy in Toxicology and Poisoning
Luisetto Mauro1*
, Ghulam Rasool Mashori2
, Oleg Yurievich Latyshev3
1
Applied Pharmacologist , European Specialist Lab Medicine , Public Hospital Pharmacist Manager,
Independent Researcher, Ima Academicians Branch Pharmacy And Pharmacology,Organization and
Management, Italy
2
Professor of Pharmacology ,Department of Medical & Health Sciences for Woman, Peoples
University of Medical and Health Sciences for Women, Pakistan
3
President of Ima academy
*Corresponding Author: Luisetto Mauro, Applied Pharmacologist , European Specialist Lab
Medicine , Public Hospital Pharmacist Manager, Independent Researcher, Ima Academicians
Branch Pharmacy and Pharmacology, Organization and Management, Italy, Email:
maurolu65@gmail.com
INTRODUCTION
According editorial clinical pharmacist maim
focus “the main focus of the clinical pharmacist
must be applied in priority way to the most
critical patients in order to achieve the best
results available. In this condition even benefit
of 1 life achieved in mortality rate is a real
golden endpoint (we can think for example to a
pediatric poisoning, or severe infectious disease
in pregnancy or the effect of inefficacy
immunosuppressive therapy in transplanted et
other) . This can be considered in example as a
reduction in NNT to improve a therapeutic
ABSTRACT
In a recent Italy regional congress it has been presented an oral presentation related the link between
management science and the toxicology in order to improve efficacy of the organizations involved in the
management od the poisoned patients. This argument was accepted with interest by the auditory (ferrara
2019 congress of antidothes and durg abuse management system and control provider university of
Ferrara). Related poisoning and toxicology is crucial for the security of patients life a medical team whit all
the professionality needed , the right avaibility of med. Lab tests, imaging , antidothes availability and other
drugs stokes to provide the really best therapy. The same adequate and rapid system of information is
relevant (poisoning centre, public institution, biomedical data bases, university library and other make the
difference: Treating Poisoning deffen a lot from a normal pharmacological therapy because antidotes of
then need of very dedicated dosage and posology to treat in very rapid way a real danger situation. (since
death). So is possible to say that is needed : right emergency procedure, right communication system, right
Clinicians (toxicologist, clinicians, imaging professionals , medicine laboratorist, clinical pharmacist
Logistic pharmacist, epidemiologist, healthcare managers and others), right procedure, right
Documentation ( poisoning, antidotes) , right and rapid flux of the relevant information (availability of rare
antidotes in other hospital or in regional or national antidotes stokes. also right ICT system, right
information about antidotes stokes and time to obtain this in emergency. (rare antidotes, unconventional
amount needed for multiple poisoning, disaster and other) Related toxicological test is requested to can
receive results (first level or second level) In the right time to modify the therapy when possible. The correct
availability of laboratory tests (toxicological, biochemistry and other). Decontaminant and depurative
strategy (dialysis, emoperfusion, iperbaric therapy et other) need the same a great and efficacy
management. (clinical, pharmaceuticla and organizative). in this work it will be used a image methods to
better introduce the managerial instruments and tequniques Useful in industry but also in administration or
health care system and so also in toxicological field. But also adequate management strategy are
fundamental to control the complex process (poisoning) in very useful way. Efficacy and effectiveness of the
entire process. Even if apical managers every day use this management instruments scope of this work is to
diffuse to all component of toxicological bio- medical team the management basic concepts and theory and
tools to obtain better clinical and economic results.
Keywords: toxicology, poisoning, management strategy, problem solving, risk management ict, emergency
department, sharing of the information, biomedical databases, mortality rate, clinical and economic
outcomes
2. The Management Strategy in Toxicology and Poisoning
35 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
strategy”. (15) Under the light of this approach
isetical and correct to apply also managerial
teqnuiques and strategy also in field of posioning
and toxicology to adequate manage severe and
complex events,like rare poisoning, disaster,
Multiple poisoning, terroristik attack, nuclear
events tha need a great organizative competence
to Act in an unusual condition.
In order to prevent incidents , to reduce
probability of errors , to right perfomr every
activity involved in Management of the
poisoned subject many managerial discipline
can help in relevant way:
Total quality management
Quality control management
Risk and safety management
MBO managemet by objective
Project management- wbs work breakdown
structure
Strategic magement- planning
Time management
Knoledge management
Data management, epidemiology
Ict management
Hta management
Problem solving
Facility management
Logistic management
HR management – leadership-teamwork-
coaching
MBWA management by walking around
Change management
Supply chain management
Clinical pharmacist management
Disaster or scenario planning strategy and many
other discipline .
Also some teqnuiques are universally consider
relevant in managemet :
gantt diagram, root causes analisys, risk
assesement, fmea, strategic analisys, swot
analisys, deming cycle, critical path analisys,
kaizen,brainstorming, problem solving, lateral
thinking, budget impact analisy, benchmarking
teqnique, pnl, transactional analisys by harris,
team leadership, matrix organization, network
organization, team building, decision tree, focus
group, scenario planning, disaster plan, to do
list, learninf by error, emotional and social
intelligence management by goleman and many
other. Attitudes and skills like : emotional
intelligence, proactivity, no extreme thinking are
only few example of right tools to be used in
critical conditon like poisoning , disaster , or
terroristic attack. Theory like : sun tzu : the art
of war, taylorism, max weber theory eli goldratt,
e.de bono, brainstorming, lateral thinking, eisen
hower matrix, Gantt diagram many many other
Intruments Like
professional social media, researchgate and
other make possible to have a great and rapid
sharing of informations about single researcher,
research topics, project and many other related
kind of Relationship between different medical
team also on distance.
This , usually integrated in every industrial of
other economic or business activity as current
way of work,Can produce high performance
also in health care settings and also in
toxicological events. So some theory and
strategies are cited in this work to provide
usefull intrument to be added to the classic
Toxicological, clinical, laboratoristic
epidemiological and other competencies. The
poisoning event need of the best biomedical
clinical information, as well as other critical
healthcare procedure: the best healthcare
professionals but also a right organization and
the right intruments.
And to have a right organization at the level
requested managemen instrument must be
adequately Performed by healthcare organization
and professionals (since from first phases of
emergency call , pre hospital setting, to the
Emergency Trasport system, to the rapid
comunication of clinical information , to the
laboratoristic assay, the antidothes availability
to the H24 consultan service of the poison
centre et other) since to the discharge phases. A
very complex system cover H24 for every day
in a year and many organization are currently
involved.
The logistic of antidothes and other remedies (in
example iperbaric oxigen therapy) need great
organization to obtain clinical and economical
results and the efficacy and effectiveness
required by actusl healthcare standard
(JACHO). Some relevant antidothes are
produced in foreing countries and to be received
the order must be sended to different countries
(procedure that require many days to be
completed) Related industrial revolution in first
3. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 36
1900 and to the military strategy a global kind
of adminitration was introduced to get the better
perfomance in an high competitive world
Management is definied as the administration of
an organization. (every kind of org.) It includes
the activities of setting the strategy for an
organization and coordinating the efforts of its
employees to accomplish its objectives through
the application of available resources, (financial,
natural, technological, and human resources.)
To manage: comes from to handle (italian
languages maneggiare latin words hand and to
act) First historic theory like sun tzu (the art of
war) since from 6 th century BC.
Figuren1.
Nicolo’ mcchiavelli (1515) the prince related
political strategy of power in itlay. 1776 adam
smith : the wealth of nation related division of
work. Henri Fayol (1841–1925)in example
considers management to consist of five
functions:
planning (forecasting)
organizing
commanding
coordinating
controlling
ManagementLEVEL : senior , middle and lower
managers level At lowe level more technical and
at the top more conceptual role. (piramid
structure) HIGH level managers set the policyof
the intere organization and make the more high
relevance decision. Lower level: in example
front line managers present more scientific -
technical competencies
Basic roles:
Interpersonal: roles that involve coordination
and interaction with employees Figurehead,
leader
Informational: roles that involve handling,
sharing, and analyzing information Nerve
centre, disseminator
Decision: roles that require decision-making
Entrepreneur, negotiator, allocator
Management skills include:
political: used to build a power base and to
establish connections
conceptual: used to analyze complex
situations
interpersonal: used to communicate,
motivate, mentor and delegate
diagnostic: ability to visualize appropriate
responses to a situation
leadership: ability to lead and to provide
guidance to a specific group
technical: expertise in one's particular
functional area.
behavioral: perception towards others.
eli goldratt: TOC theory of constraints
FiigureN2.
FigureN3. Root Causes Analysis
FigureN4.
4. The Management Strategy in Toxicology and Poisoning
37 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
FigureN5.
FigureN6.
FigureN7.
FigureN8.
FigureN9. E. De Bono Six Hats Theory
FigureN10.
FigureN11
FigureN12. Gantt diagram time management
5. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 38
FigureN13. Swot Analisys
FigureN14.
FigureN15.
FigureN16.
FigureN17.
FigureN18
Time Management
FigureN19. Plan do Check Act Cycle
FigureN20.
6. The Management Strategy in Toxicology and Poisoning
39 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
FigureN21
FigureN22.
FigureN23.
FigureN24.
FigureN25.
FigureN26.
Other examples can be Taylor 1900 scientific
management behavioral management 1900 u.
Munsterberg (industrial psychologist) Gantts
charts: 1910 for planning and scheduling max
Weber 1900 administrator as bureaucrat theory
Ronald fisher: 1900 statistical methods in
management settings Patrick blackett : similar to
the Taylor scientific management,
mathematical principle applied in military
settings public and administrative management
theory Maslow and mc gregor human relation
7. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 40
movement , hierarchy piramids of need and
theory x- and y quantitative management the
contingency perspective contemporary
management crisis management 1980/from :
Guidelines for poison control II. Technical
guidance-7. Antidotes and their availability
“National distribution of antidotes who https: //
www.who.int/ipcs/ publications /training_
poisons /guidelines poison_ control /en/index7.
html “Demographic, geographical, and economic
factors sometimes hinder the availability of
antidotes. In addition, the high cost that results
from infrequent demand and short shelf-life may
prevent their widespread distribution. A central
"bank" of antidotes could be an economic and
effective means of ensuring distribution, and
this should be organized by health authorities in
such a way that any poison victim may be
assured of receiving an antidote within the
appropriate period of time.
Economic Aspects
When considering the cost of antidotes,
governments should take into account the social
and medical consequences of failure to treat
poisoned patients in an appropriate manner and
the continued economic burden on local or
national resources that may ensue. In general,
pharmaceutical companies will manufacture and
supply antidotes only if they are encouraged by
adequate economic returns for their investment
and by simple registration procedures. To this
end, governments should consider recent WHO
recommendations1 concerning products for
export and facilitate the registration of antidotes
already evaluated and registered elsewhere.
If antidotes cannot be supplied by the
pharmaceutical industry, other means of ensuring
their availability should be considered. These
could include the establishment of government
manufacturing facilities, a manufacturing
pharmacy laboratory, or a system that allows the
importation of antidotes registered elsewhere.
Other ways of using resources efficiently, such
as rationalizing the purchase and distribution of
antidotes, should also be considered by health
authorities and should take into account the time
within which antidotes need to be available for
use in treatment. Local transport conditions
should also be considered. Antidotes needed
immediately must be stocked at all hospitals, as
well as in health centers or doctors' surgeries if
the nearest hospital is some distance away. It
may also be necessary to have certain antidotes
available at places of work for use under
medical supervision (e.g. in factories using
cyanide). Antidotes needed within 2 hours can
be stocked at certain main hospitals; patients can
be taken to these hospitals for treatment or the
antidotes can be transported - within the time
limit - to the health facilities at which treatment
is provided. Antidotes needed within 6 hours
may be stocked at central regional depots,
provided that there are adequate facilities for
transporting them within the time limit. For all
categories of antidotes, there is the further
option of keeping a small amount, sufficient to
start treatment, in stock locally, further supplies
being obtained from a central source as
required. Where certain types of poisoning are
frequent, or in areas where certain chemicals are
heavily used, the appropriate antidotes may be
kept in ambulances, operated by physicians, that
are sent out to treat cases of poisoning.
Poisoning by natural toxins may be seasonal and
may be specific to certain regions (e.g. snake-
bites in rural areas during planting and
harvesting seasons). Antivenoms may be sent to
rural areas during these seasons to be readily
available in case of need. The rapid transport of
antidotes may be needed in certain circumstances,
and appropriate advance arrangements should be
made, e.g. for the use of official cars, aircraft, or
trains. In certain situations, arrangements for the
rapid transport of patients to hospitals with
appropriate facilities and antidotes may be
necessary. Comprehensive instructions on
interim treatment measures should be given to
first-aid workers or other medical or
paramedical professionals.
Improving Availability
The difficulties experienced in obtaining
antidotes for the treatment of poisoned patients
vary from country to country. While research in
certain areas by industry, and at the international
level, could improve the general availability of
antidotes, each country will need to identify its
own particular problems and take specific action
to solve them. A combination of measures will
be required, and collaboration will be necessary
between the various individuals and
organizations involved.”
MATERIAL AND METHODS
Whit an observational method some relevant
literature (in our opinion) are analyzed in order
to produce a global Conclusion to submit to the
researcher an useful instrument to be deeply
applied in toxicological setting To give to the
severe poisoned patient the best organizative
process.(1-14)
8. The Management Strategy in Toxicology and Poisoning
41 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
The same this instrument make possible to have
a right instrument to manage also very complex
situation in example due by terroristic chemical
or bacteriological accatsk or multiple cases of
intoxication (nuclear Incident and other).
All literature comes from biomedical databases
like PUBMED or from other open access
journal. After this review are analyzed the result
of a practical experience in a public hospital
setting (provincial hospital with about 700 beds
PC area, with 4 hospital linked).
This Public hospital is linked with other
provincial hospital and regional centre rear for
antidothes. Hub and spoke system.
RESULTS FROM LITERATURE
Janati A Et Al
“Purpose Hospital manager decisions can have a
significant impact on service effectiveness and
hospital success, so using an evidence-based
approach can improve hospital management.
The purpose of this paper is to identify
evidence-based management (EBM gt)
components and challenges. Consequently, the
authors provide an improving evidence-based
decision-making framework. Design/
methodology/approach a total of 45 semi-
structured interviews were conducted in 2016.
The authors also established three focus group
discussions with health service managers. Data
analysis followed deductive qualitative analysis
guidelines. Findings Four basic themes emerged
from the interviews, including EBM gt evidence
sources (including sub-themes: scientific and
research evidence, facts and information,
political-social development plans, managers'
professional expertise and ethical-moral
evidence); predictors (sub-themes: stakeholder
values and expectations, functional behavior,
knowledge, key competencies and skill,
evidence sources, evidence levels, uses and
benefits and government programs); EBM gt
barriers (sub-themes: managers' personal
characteristics, decision-making environment,
training and research system and organizational
issues); and evidence-based hospital
management processes (sub-themes: asking,
acquiring, appraising, aggregating, applying and
assessing). Originality/value Findings suggest
that most participants have positive EBM gt
attitudes. A full evidence-based hospital
manager is a person who uses all evidence
sources in a six-step decision-making process.
EBM gt frameworks are a good tool to manage
healthcare organizations. The authors found
factors affecting hospital EBM gt and identified
six evidence sources that healthcare managers
can use in evidence-based decision-making
processes.” (16)
Rashid Al-Abri
“One of the key concerns in Health care
management is management of change and
health care professionals are obligated both to
acquire and to maintain the expertise needed to
undertake their professional tasks, and all are
obligated to undertake only those tasks that are
within their competence.1 Moreover, change
occurs continuously around us. We may want to
support it, be indifferent to it, and be passive or
participate in it. The pace of change has
increased dramatically.2
Managing change is about handling the
complexity of the process. It is about evaluating,
planning and implementing operations, tactics
and strategies and making sure that the change
is worthwhile and relevant.3 Managing change
is a complex, dynamic and challenging
process.4 It is never a choice between
technological or people-oriented solutions but a
combination of all.” (17)
Matthias Briner Et Al
“Clinical risk management (CRM) plays a
crucial role in enabling hospitals to identify,
contain, and manage risks related to patient
safety. So far, no instruments are available to
measure and monitor the level of implementation
of CRM. Therefore, our objective was to
develop an instrument for assessing CRM in
hospitals. “(18) New instruments as professional
social media can give more opportunity to meet
researcher in healthcare field. Luisetto et al int.
journal of economics and management sciences
2016 [18,19], Instrument to rapid share the
information between healthcare professionals
and to transfer research activities to practical
settings“(19) And in article : New ICT
Technologies to Improve Clinical Outcome in
Toxicology and Poisoning. Open Acc J of
Toxicol. 2017 Is reported that: “We strongly
ask to international organization involved in
hospital standard accreditations requirement to
introduce as relevant instrument a informatics
management system (cabinet informative or
other systems) in logistics of antidothes.
This will make possible a correct management
and to have available the right antidothes in
right time for the safety of the poisoned patients
9. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 42
and also for professionals. As we have seen in
example for emergency drug hospital systems
we can have also a reduction in total costs
providing an efficiency system. (Almost 53.000
euro in 5 years in an Italian public hospital) [14]
we can think in example to total cost avoided if
introduced in many national hospital. This kind
of experience can be usefully translated to
antidotes and toxicology filed in many hospital
places. This modify in routine can reduce
mortality rate due by due by incorrect antidotes
stokes logistics improving also the clinical
outcomes related. In example we can see that in
different hospital also the stokes and availability
in some classic antidotes as activated charcoal
can be insufficient and related the cyanide
antidothes we have see that this is not correctly
available in the different world hospital situation
related to the difficulty to of industries or other
condition that contribute to the variability in the
request). Also the logistics of rare antidothes is a
crucial process (the expiration time control and
ordering procedure of this molecules can be part
of an inefficient systems if not adequately
controlled). We can also see that a velocity
management ICT strategy can gives improving
in the efficacy of process related to logistics and
to translate rapidly the relevant information in
poisoning situations. In our conclusion adding
the ICT power and the clinical pharmaceutical
care competences and knowledge added to the
toxicological medial team we can have more
clinical results reducing mortality rates and
healthcare costs.” (20)
Trisolini MG
“Most health care management training
programmes and textbooks focus on only one or
two models or conceptual frameworks, but the
increasing complexity of health care organizations
and their environments worldwide means that a
broader perspective is needed. This paper
reviews five management models developed for
business organizations and analyses issues
related to their application in health care. Three
older, more 'traditional' models are first
presented. These include the functional areas
model, the tasks model and the roles model.
Each is shown to provide a valuable perspective,
but to have limitations if used in isolation.
Two newer, more 'innovative' models are next
discussed. These include total quality
management (TQM) and reengineering. They
have shown potential for enabling dramatic
improvements in quality and cost, but have also
been found to be more difficult to implement. A
series of 'lessons learned' are presented to
illustrate key success factors for applying them
in health care organizations. In sum, each of the
five models is shown to provide a useful
perspective for health care management. Health
care managers should gain experience and
training with a broader set of business management
models” (21)
A El Taguri
“Health services have the functions to define
community health problems, to identify unmet
needs and survey the resources to meet them, to
establish SMART objectives, and to project
administrative actions to accomplish the purpose
of proposed action programs. For maximum
efficacy, health systems should rely on newer
approaches of management as management-by-
objectives, risk-management, and performance
management with full and equal participation
from professionals and consumers. The public
should be well informed about their needs and
what is expected from them to improve their
health. Inefficient use of budget allocated to
health services should be prevented by tools like
performance management and clinical
governance. Data processed to information and
intelligence is needed to deal with changing
disease patterns and to encourage policies that
could manage with the complex feedback
system of health. E-health solutions should be
instituted to increase effectiveness and improve
efficiency and informing human resources and
populations. Suitable legislations should be
introduced including those that ensure
coordination between different sectors. Competent
workforce should be given the opportunity to
receive lifetime appropriate adequate training.
External continuous evaluation using appropriate
indicators is vital. Actions should be done both
inside and outside the health sector to monitor
changes and overcome constraints.” (22)
Gunther Eysenbach Et A
“A strong majority of the literature shows
positive effects of HIT on the effectiveness of
medical outcomes, which positively supports
efforts that prepare for stage 3 of meaningful
use. This aligns with previous reviews in other
time frames.” (23)
John Wright Et Al
“Problem: There are wide variations in hospital
mortality. Much of this variation remains
unexplained and may reflect quality of care.
Setting: A large acute hospital in an urban
district in the North of England.
10. The Management Strategy in Toxicology and Poisoning
43 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
Design: Before and after evaluation of a hospital
mortality reduction program.
Strategies for change: Audit of hospital deaths
to inform an evidence-based approach to
identify processes of care to target for the
hospital strategy.
Establishment of a hospital mortality reduction
group with senior leadership and support to
ensure the alignment of the hospital departments
to achieve a common goal. Robust measurement
and regular feedback of hospital deaths using
statistical process control charts and summaries
of death certificates and routine hospital data.
Whole system working across a health
community to provide appropriate end of life
care. Training and awareness in processes of
high quality care such as clinical observation,
medication safety and infection control.
Effects: Hospital standardized mortality ratios
fell significantly in the 3 years following the
start of the programme from 94.6 (95%
confidence interval 89.4, 99.9) in 2001 to 77.5
(95% CI 73.1, 82.1) in 2005. This translates as
905 fewer hospital deaths than expected during
the period 2002-2005.
Lessons learnt: Improving the safety of hospital
care and reducing hospital deaths provides a
clear and well supported goal from clinicians,
managers and patients. Good leadership, good
information, a quality improvement strategy
based on good local evidence and a community-
wide approach may be effective in improving
the quality of processes of care sufficiently to
reduce hospital mortality.” (24)
Mike English Et Al
“There is increasing focus on the strength of
primary health care systems in low and middle-
income countries (LMIC). There are important
roles for higher quality district hospital care
within these systems. These hospitals are also
sources of information of considerable
importance to health systems, but this role, as
with the wider roles of district hospitals, has
been neglected. As we make efforts to develop
higher quality health systems in LMIC we
highlight the critical importance of district
hospitals focusing here on how data on hospital
mortality offers value: i) in understanding
disease burden; ii) as part of surveillance and
impact monitoring; iii) as an entry point to
exploring system failures; and iv) as a lens to
examine variability in health system
performance and possibly as a measure of health
system quality in its own right. However,
attention needs paying to improving data quality
by addressing reporting gaps and cause of death
reporting. Ideally enabling the collection of
basic, standardized patient level data might
support at least simple case-mix and case-
severity adjustment helping us understand
variation. Better mortality data could support
impact evaluation, benchmarking, exploration of
links between health system inputs and
outcomes and critical scrutiny of geographic
variation in quality and outcomes of care.
Improved hospital information is a neglected but
broadly valuable public good. Accurate,
complete and timely hospital mortality reporting
is a key attribute of a functioning health system.
It can support countries’ efforts to transition to
higher quality health systems in LMIC enabling
national and local advocacy, accountability and
action.”(25)
Jean-Michel Yeguiayan Et Al
“Severe blunt trauma is a leading cause of
premature death and handicap. However, the
benefit for the patient of pre-hospital
management by emergency physicians remains
controversial because it may delay admission to
hospital. This study aimed to compare the
impact of medical pre-hospital management
performed by SMUR (Service Mobile d'
Urgences et de Ré animation) with non-medical
pre-hospital management provided by fire
brigades (non-SMUR) on 30-day mortality.
The FIRST (French Intensive care Recorded in
Severe Trauma) study is a multicenter cohort
study on consecutive patients with severe blunt
trauma requiring admission to university
hospital intensive care units within the first 72
hours. Initial clinical status, pre-hospital life-
sustaining treatments and Injury Severity Scores
(ISS) were recorded. The main endpoint was 30-
day mortality.
Among 2,703 patients, 2,513 received medical
pre-hospital management from SMUR, and 190
received basic pre-hospital management
provided by fire brigades. SMUR patients
presented a poorer initial clinical status and
higher ISS and were admitted to hospital after a
longer delay than non-SMUR patients. The
crude 30-day mortality rate was comparable for
SMUR and non-SMUR patients (17% and 15%
respectively; P = 0.61). After adjustment for
initial clinical status and ISS, SMUR care
significantly reduced the risk of 30-day
mortality (odds ratio (OR): 0.55, 95% CI: 0.32
to 0.94, P = 0.03). Further adjustments for the
11. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 44
delay to hospital admission only marginally
affected these results.
This study suggests that SMUR management is
associated with a significant reduction in 30-day
mortality. The role of careful medical
assessment and intensive pre-hospital life-
sustaining treatments needs to be assessed in
further studies” (26).
According article pharmaceutical care and
toxicology “Poisoning is a rare event often, but
in some cases whit critical consequences and so
the right diagnosis and therapy is a golden end
point. The toxicology medical equip must be
multi-professional. Observing the results of
bibliography citied in this works and some
university toxicology programs for pharmacists
when observe that the clinical pharmacist
presence in stabile way in toxicologist medical
team give improving in clinical outcomes.
Antidotes are used not often but rarely, and
physicians need rapid information also in
medicinal chemistry and toxicology field. The
management of the systems must involve
clinical and logistic pharmacist. The pathology,
toxicology, pharmacology and medicinal
chemistry competence of clinical pharmacist
added to the emergency and ICU physician’s
competences can be the right keywords. The
skills requested to the clinical pharmacist in
order to works in efficiently way in
toxicological medical team are: pro activity,
learn about error, critical thinking, collaborative,
approach, management ability, problem solving
risk management (therapy errors management,
some example and causes. illegible
handwriting), we think that in order to have a
more and efficacy inclusion of clinical
pharmacist in the toxicologist equip also
psychological and behavior specific skill are
useful instruments .
New instruments as professional social media
can give more opportunity to meet researcher in
healthcare field. , Instrument to rapid share the
information between healthcare professionals
and to transfer research activities to practical
settings. (27)
And in article New ICT Technologies to
Improve Clinical Outcome in Toxicology and
Poisoning. Open Acc J of Toxicol. 2017 “We
strongly ask to international organization
involved in hospital standard accreditations
requirement to introduce as relevant instrument
a informatics management system (cabinet
informative or other systems) in logistics of
antidothes. This will make possible a correct
management and to have available the right
antidothes in right time for the safety of the
poisoned patients and also for professionals.
As we have seen in example for emergency drug
hospital systems we can have also a reduction in
total costs providing an efficiency system.
(Almost 53.000 euro in 5 years in an Italian
public hospital) we can think in example to total
cost avoided if introduced in many national
hospital. This kind of experience can be usefully
translated to antidotes and toxicology filed in
many hospital places. This modify in routine
can reduce mortality rate due by due by
incorrect antidotes stokes logistics improving
also the clinical outcomes related. In example
we can see that in different hospital also the
stokes and availability in some classic antidotes
as activated charcoal can be insufficient and
related the cyanide antidothes we have see that
this is not correctly available in the different
world hospital situation related to the difficulty
of industries or other condition that contribute to
the variability in the request). Also the logistics
of rare antidothes is a crucial process (the
expiration time control and ordering procedure
of this molecules can be part of an inefficient
systems if not adequately controlled). We can
also see that a velocity management ICT
strategy can gives improving in the efficacy of
process related to logistics and to translate
rapidly the relevant information in Poisoning
situations.
In our conclusion adding the ICT power and the
clinical pharmaceutical care competences and
knowledge added to the toxicological medial
team we can have more clinical results,
Reducing mortality rate and healthcare costs
(28) in article Rethinking the Hospital
Pharmacist Service: Centralized Logistics– Ict
Systems and Clinical Pharmaceutical Care002
Strategies as a Management Opportunity for
Public and Private Institutions is possible to
verify that : “In last year’s healthcare costs are
increased constantly in logarithmic way and this
conditions need an high efficiently resource
management system more than past. Drugs,
medical devices, diagnostics or medical errors
are relevant voice in the public and private
hospital current budget and healthcare
Institution and government tray every day to
control it. (U.S. HEALTH national expenditure
amounted total 3.0 -3billion U.S. D.
The total spending on medicine in the USA was
about 6 more than 400 us dollars in 2015).An
12. The Management Strategy in Toxicology and Poisoning
45 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
high performance HEALTHCARE org. Need
today: deep innovations, right management of
materials (LOGISTICS drugs and medical
devices use), new technologies knowledge, risk
management skills and other resource.”(29) And
in article : “Attitudes and Skills in Business
Working Settings: A HR Management Tool”
“This study move from the necessity to cover
the need by professionals and public or private
organization to reduce the high costs involved in
some inefficient performances level. Today
more than past working settings are very
complex (also due by to days company
competitiveness needs, cultural differences of
workers, different educational and university
course, personal goal setting, personal attitudes
and other relevant aspect). High costs are
involved in not efficiently in human resource
management or by not rapid introduction of the
new UR the new staffs. The total cost of human
resource can be reduced of about 30% using a
correct management strategic planning in order
to obtain a more rapid and efficient introduction
in the working places. Rationalize it is a golden
endpoint as well as a real competitive advantages
for the same company and organizations and
instrument to well-being for the same
professionals. The cost due by inadequate
behavior or psychological profile and HR
Management is crucial instrument of company
competition.
Observing the new kind of works in example in
ICT technology, social networks and other
market we can see that the creativity and workers
wellness are successful tools to differentiating
Technologies Products by different producers
giving improvement of sales volume. (Old and
new economy differs also by the different
concept of works: in new economy we can have
less strictly working condition but more results
oriented. Less hierarchic control vs. old
economy industry). The aim of this work is to
observe the actual situation of education in field
of emotional intelligence field and then to give
some instruments that can be used by
professionals in the different working settings in
order to have a good and rapid introduction and
to obtain improvement also in global
performances. (Instruments for well-being for
the same professionals: Stressing working
conditions easy gives also stress in private life.)
Today more than past working activities are
under great competition and rapid change
(according to the company competitive needs),
less defined and with more fluid roles , the
working time in office/or out of office can
change a lot, more new technologies available
then past, more functional organizations towards
hierarchy roles. All this new condition creates a
hard environment (more than past results
oriented).
So the organization researches the best
professionalism available (with right HR
management skills, Hig E.I. LEVEL, high
behavior and psychological resilience ability
and other skills useful for today jungle). So
there is a great need to reduce the gap
represented by behavior and psychological skills
level required by company and the level of the
professionals obtained in their educational life
(schools, university, post university course). to
be in condition to obtain high performances
since first working experiences. Everyone can
see that many professionals start their
professional activity without a minimal level of
emotional or social intelligence skills. Training
systems and coaching can help but are needed
deep knowledge in human resource
management, and practical application.
In the working places today there is the need to
have great skills in communications, conflict
management, and pro activity, resilience,
learning by errors, perseverance, critical thinking
and much other discipline. Psychological
attitudes and skills can influence the working
performance level. In example is known that
often negative thinking attitude (tunnel thinking)
can create in mind preferential ways easy to be
run and this can create problems in the
management of their thinking process with low
performances level. (Some mindfulness strategy
can help to improve Psychological attitudes and
reducing negative stress). The same thinking in
the present time (observing too much the past
gives trouble thinking while thinking too much
the future can gives anxiety) help the mind can
reinforce itself. Creativity can reduce anxious
attitudes. About 70% of works ability and
success depends on emotional intelligence
versus 30 % technical abilities (Remember
Pareto paradigm 20/80 similar). The emotional
intelligence theory shows that the emotional
brain can be more rapid in responding to some
stress stimulus then the rational thinking. For
example studies showed that Amygdala physio-
pathology is involved in E. I. management and
can give in this situation rapid response without
waiting for the cortical brain control. (neo-
cortex / reptilian brain) .
When in the same time many strong emotions
stimulation arrives too fast to amygdala the neo
13. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 46
cortex is not involved. An easy reactive
amygdala can results in working difficulties in
relationship in equip. Low level of social
intelligence gives isolation and depression and
low working performances. Conflict are natural
in all context and so in working setting. The
self-motivation is strongly involved in
professional development. Successful status is
related with high emotional, social and political
attitudes. But even if the technical competences
are subjects of usual educational and university
policy we see a real gap for the emotional social
and relational development in student
curriculum. So in this work, we try to give some
elements for improving behavior skills to be
active and efficient part of a professional team
or to prevent and resolve conflict. In our opinion
some theory are to be post under right light: and
for example: De Bono Seven hats and Lateral
thinking (problem solving approach), E.
Goldratt TOC Theory of constraints, about
psychological limits (a management theory),
translational analysis, emotional and social
intelligence, Pareto paradigm, GANTT diagram,
Eisenhower matrix, Deming cycle (total quality
management), MASLOV hierarchy of need, but
they only the first of many other.”(30)
Jacobsen DETAL
“Antidotes may play an important role in the
treatment of poisoning. For many physicians
and toxicologists an antidote is an antidote.
According to the IPCS definition, an antidote is
a therapeutic substance used to counteract the
toxic action(s) of a specified xenobiotic. Given
this wide definition, the efficacy of an antidote
may vary considerably depending on which
toxic action(s) is/are being counteracted and on
the level of counteracting power: An almost
100% efficacy is seen using specific antagonists,
such as naloxone in opiate poisoning or
flumazenil in benzodiazepine poisoning, e.g.
resulting in complete reversal of opiate toxicity
unless complications, such as anoxic brain
damage, have developed. At the other end of
the efficacy scale, we may place chelating
agents for heavy metal poisoning and diazepam
for organophosphorus insecticide poisoning.
Therefore, in the IPCS/EC evaluation series of
antidotes, some chelating agents are considered
only to be an adjunct to supportive care which is
the cornerstone of treatment. When teaching
clinical toxicology or recommending the use of
antidotes in poisoned patients, the expected
efficacy level of the antidote in question should
be stressed. This may be particularly important
in severe poisonings when the antidote may only
be considered as an adjunct to supportive care,
e.g. deferoxamine in acute iron poisoning.
Unless this is stressed, the un experienced
physician may rely too much on the antidote and
may not pay sufficient attention to the
supportive care. In this presentation, the varying
efficacy levels of antidotes are discussed as
based on the presently ongoing IPCS/EC
evaluation programme on antidotes. “(31) In
publication : Emergency Pharmaceutical Care in
ED and ICU: Toxicology, Infectious Disease,
Life Saving Drugs Management, Pharma co
economy as Synergic Knowledge Instrument to
Reduce Mortality Rate and Healthcare Cost
2019 “If in emergency medicine time is
universally considered “TIME ISBRAIN” in
stroke management (and the golden hour) the
pharmacist clinical competencies is a
fundamental fact for patient safety in the
medical team (in example for administration of
anti bioticsin sepsis , thrombolythic therapy,
antidotes administration and other) . The clinical
pharmacist competencies related intensive care
drugs, pharmacology, toxicology, medicinal
chemistry, medical devices, infectious disease,
cardiovascular, renal, epatic, neurology Bone
marrow, pulmonary functions and many other in
example TDM therapeutic drug monitoring
Medicine lab competencies, Pharma co
economy are currently present in curricula
studio rum of many clinical pharmacy
International course. So Is clear that the clinical
pharmacist and pharmaceutical care skills can
be the right instrument to reduce mortality rate
and cost containment. The same the economic
results of this approach is a clear undeniable
fact. The Clinical Pharmacist Interest is mainly
on Some Drugs Classes Management in EM or
ICU:
Like
Antidotes (A and B priority)
Hemo-derivates
Some parenteral antimicrobials
Anahestetics, Miorelaxants, analgesics and
narcotics
Cardio active
Electrolites
Anti pertensive , diuretics
Anti epileptics
And Other necessary Emergency drugs to cover
the various emergency need (compoundings,
magistral formula) and few other classes.”(32)
and in a ICU setting “Observing the results of
the bio medical literature reported in this work
we can say that the clinical pharmacist presence
14. The Management Strategy in Toxicology and Poisoning
47 International Journal of Research in Business Studies and Management V6 ● I6 ● 2019
in stabile way in ICU medical team gives
improving in some clinical patient’s outcomes
and reducing mortality rate. This conclusion is
related to the complexity of ICU SETTINGS
and by critical patient’s condition. To
adequately managed this situations are needed
the most complete medical equips (multi
disciplinariety). We observe that the role played
by hospital pharmacists can be in more clinical
activities, as educator (towards all healthcare
professionals), researcher, and manager
functions.” (33) Results of a practical
experience: Location PC area 29121Setting
public provincial hospital Time of observation:
2008-2018 Position observed: hospital
pharmacist manager (applied pharmacologist)
involved in antidothes management provincial
stokes. Hospital pharmacist manager whit tqm
total quality management course. (uni one
industrial to 1996 ). Way of execution: under a
pharmaceutical and managerial approach
Results: during this periods of time no event
related to lack of availability in antidothes
stokes that causes relevant or letal patient
damages. ( no notification from official hospital
office). only few times needed to get some
antidothes molecules (from other hospital or
poison centre or from regional hub for antidothes
to treat patients but with out any clinical
complications). Every year was respected budget
related antidothes. (This result was obtained
WITH the CRR regional antidothes centre and
CAV PV collaboration). The antidothes hospital
stokes in PC area are present in emergency
department, ICU, pharmacy And Blood bank
.Great collaboration between medical equip of
emergency department, ICU, hospital pharmacy
regional hub, poison centre contacted.
DISCUSSION
Every level of healthcare managers (high, but
also lower) MUS use manager instruments to
adequately perform high risk job. Many
managerial theory or tools are efficacy applied
in many settings with high results as Outcomes.
Related this real efficacy documented is crucial
to transfer this methods also I health care setting
and Also in toxicological medical team
(poisoning and other) to get the best clinical and
economical results and for the safe of patient
life involved.
Many serious condition like severe poisoning,
rare poisoning, multiple cases, disaster,
terroristic attack, nuclear incident and other
need complex and rapid response and the
organization added to the healthcare professionals
make the difference.” Related the result
presented of a practical experice is possible to
say that a strictly observance of antidothes
normative rules added to a specific managerial
competence of hospital pharmacist make
possible an adequate performance towards
patients safety in a very dangerous setting like
toxicology and poisoning. Hospital pharmacist
managers with high competencies also in TQM
make possible to be Facilitator between toxicology
medical team, HUB regional antidothes centre
CRR RER, central medical office, national
stockpile of antidotes , ministerial of health office
,polices forces , inside ministry office
pharmaceutical industries, import company of
drugs and all other member involved in this
kind of process.
CONCLUSION
Related the result of this bibliographic research,
the practical experience presented and all the
current Managerial instruments and theories is
undeniable that this last tools must be deeply
introduced and applied in toxicological setting
to obtain the best possible clinical results in
cases of severe or complex poisoning. The right
flux of relevant information about poisoned
patients or related antidothes characteristic
provided by poison center make possible to
achieve the best clinical result possible. The
result presented in this work was obtained using:
ICT instruments, managerial strategy, clinical
pharmacist competencies, HR management, risk
management and other techniques we have see.
Under the light of this practical experience and
literature presents is crucial to ask to International
org. involved in hospital accreditation and other
public institution (ministry of health, universities
and other) to deeply introduce managerial
concepts and skills in all component of medical
team involved in severe poisoning to achieve the
best result available. in order to setting the best
strategy in poisoning and toxicology field is
strongly requested deeply knowledge related the
toxic mavens and related to the antidothes and
supportive or depurative strategy or
laboratoristic competencies but also high
healthcare professionals managerial training. If
“time is life” in some medical emergencies the
same is possible to consider that and adeguate
management of all component of toxicological
team from the access to ED to the discharge of a
poisoned patient is a fundamental basis to the
best therapeutic strategy.
15. The Management Strategy in Toxicology and Poisoning
International Journal of Research in Business Studies and Management V6 ● I6 ● 2019 48
REFERENCES
[1] IPCS: international programme on chemical
safety-antidotes the use of essential drugs.
Model list of essential drugs (ninth list).
Seventh report of the who expert committee.
geneva; world health organization, 1997 (who
technical report series, no. 867.
[2] CAV Pavia maugeri antidothes clinical use
guideline 2018-2019.
[3] racc. Minister o della salute (Italy)
n.7 raccomandazione per la prevenzione
dellamorte, coma o grave danno derivati da
errori in terapia farmacologica.
[4] the emergency drug cabinet system: l’armadio
delle urgenze gestito dal farmacista ospedaliero
congresso sifo 2016
[5] official pharmacopeia italy , European, USA
[6] CRR centro regionale antidoti Ferrara regione
Emilia Romagna https:/ /antidoti.ospfe.it/
[7] CAV centro antiveleni e centro nazionale di
informazione tossicologica di Pavia http:/
/www-3.unipv.it/ reumatologia-tossicologia
/cav/
[8] allegato III gazette uff. european
[9] Management website https:// www. 12manage.
com/
[10] Pmbok project management last version
[11] JACHO in force guideline fo accreditation of
healthcare org.
[12] in force activation procedure of national and
regional stockpile of antidothes
[13] Decreto del presidente del consiglio dei
ministri, 12 gennaio 2017 articolo 46 - centri
antiveleni. “il servizio sanitario nazionale
garantisce attraverso i centri antiveleni (cav)
attività di consulenza specialistica per
problematiche di carattere tossicologico di alta
complessità, a supporto delle unità operative di
pronto soccorso e degli altri servizi ospedalieri
e territoriali, nonchè adeguati sistemi di
sorveglianza, vigilanza e allerta”
[14] Regional congress 2019 the emilia romagna
antidothes management systems and drugs of
abuse network ferrara provider university of
Ferrara 10/06/2019
[15] J Appl Pharm, an open access journal 2017,
9:4 DOI: 10.21065/1920-4159.1000e114
The Clinical Pharmacists Main Focus M
Luisetto, B. Nili , G. R Mashori
[16] Int J Health Care QualAssur. 2018 Jun 11;
31(5):436-448. doi: 10.1108/IJHCQA-08-2017-
0143. Evidence-based management - healthcare
manager view points. Janati A1, Hasanpoor E2,
Hajebrahimi S3, Sadeghi-Bazargani H4
[17] Oman Med J. 2007 Oct; 22(3): 9–10. Managing
Change in Healthcare Rashid Al-Abri*
[18] BMC Health Serv Res. 2010; 10: 337.
Assessing hospitals' clinical risk management:
Development of a monitoring instrument Matthias
Briner, corresponding author#1,2 Oliver
Kessler,#2 Yvonne Pfeiffer,1 Theo Wehner,1 and
Tanja Manser#3
[19] Luisetto M (2016) Pharmaceutical Care and
Toxicology, a Synergy in High Risk Situation. J
App Pharm 8: 231. doi: 10.21065/1920-
4159.1000231
[20] Luisetto M. New ICT Technologies to Improve
Clinical Outcome in Toxicology and Poisoning.
Open Acc J of Toxicol. 2017;2
[21] Int J Health Plann Manage. 2002 Oct-Dec;
17(4):295-314. Applying business management
models in health care. Trisolini MG1.
[22] Libyan J Med. 2008; 3(3): 148–155. Essential
Concepts in Modern Health Services A El
Taguri
[23] J Med Internet Res. 2018 Feb; 20(2): e41.
Health Information Technology Continues to
Show Positive Effect on Medical Outcomes:
Systematic Review Monitoring Editor: Gunther
Eysenbach Reviewed by Ibrahim Adeleke,
Colin Fincham, Sebastian Garde, and Anne
Ekeland Clemens Scott Kruse, MBA, MHA,
MSIT, PhD corresponding author1 and
Amanda Beane, BA#1
[24] J R Soc Med. 2006 Jun; 99(6): 303–308.
Learning from death: a hospital mortality
reduction programme John Wright,1 Bob
Dugdale,2 Ian Hammond,3 Brian Jarman,4
Maria Neary,5 Duncan Newton,6 Chris
Patterson,7 Lynne Russon,8 Philip Stanley,9
Rose Stephens,10 and Erica Warren11
[25] BMC Med. 2018; 16: 32.Hospital Mortality – a
neglected but rich source of information
supporting the transition to higher quality
health systems in low and middle income
countries Mike English, corresponding
author1,2 Paul Mwaniki,1 Thomas Julius,1
Mercy Chepkirui,1 David Gathara,1 Paul O.
Ouma,1 Peter Cherutich,3 Emelda A. Okiro,1
and Robert W. Snow1,2
[26] Crit Care. 2011; 15(1): R34. Published online
2011 Jan 20. Doi: 10.1186/cc9982 Medical pre-
hospital management reduces mortality in
severe blunt trauma: a prospective
epidemiological study Jean-Michel Yeguiayan,
corresponding author1 Delphine Garrigue,2
Christine Binquet,3 Claude Jacquot,4 Jacques
Duranteau,5 Claude Martin,6 Fatima Rayeh,7
Bruno Riou,8 Claire Bonithon-Kopp, 3 and
Marc Freysz1, The FIRST (French Intensive
Care Recorded In Severe Trauma) Study Group
[27] Luisetto M (2016) Pharmaceutical care and
toxicology: a synergy in high risk situation. J
Appl Pharm 8: 1-7.
[28] Luisetto M. New ICT Technologies to Improve
Clinical Outcome in Toxicology and Poisoning.
Open Acc J of Toxicol. 2017;2 (2):002 555581.
DOI: 10.19080 /OAJT.2017. 02.555581.